Paeonol suppresses solar ultraviolet-induced skin inflammation by targeting T-LAK cell-originated protein kinase
Metrics: PDF 667 views | HTML 921 views | ?
Peipei Xue1,*, Yong Wang1,*, Fanfan Zeng1, Ruijuan Xiu1, Jingwen Chen2, Jinguang Guo2, Ping Yuan1, Lin Liu1, Juanjuan Xiao1, Hui Lu1, Dan Wu1, Huaxiong Pan3, Mingmin Lu2, Feng Zhu1, Fei Shi2, Qiuhong Duan1
1Department of Biochemistry and Molecular Biology, School of Basic Medicine, Huazhong University of Science and Technology, Wuhan, 430030, China
2Department of Dermatology of The General Hospital of Air Force, Beijing, 100142, PR China
3Department of Pathology, Union Hospital, Huazhong University of Science and Technology, Wuhan, 430030, China
*These authors have contributed equally to this work
Feng Zhu, email: firstname.lastname@example.org
Fei Shi, email: email@example.com
Qiuhong Duan, email: firstname.lastname@example.org
Keywords: TOPK, paeonol, solar UV, skin inflammation, MAPK
Received: November 24, 2016 Accepted: January 24, 2017 Published: February 23, 2017
Excessive exposure to solar UV (SUV) is related with numerous human skin disorders, such as skin inflammation, photoaging and carcinogenesis. T-LAK cell- originated protein kinase (TOPK), an upstream of p38 mitogen-activated protein kinase (p38) and c-Jun N-terminal kinases (JNKs), plays an important role in SUV -induced skin inflammation, and targeting TOPK has already been a strategy to prevent skin inflammation. In this study, we found that the expression of TOPK, phosphorylation of p38 or JNKs was increased in human solar dermatitis tissues. The level of phosphorylation of p38 or JNKs increased in a dose and time dependent manner in HaCat cells or JB6 Cl41 cells after SUV treatment. Paeonol is an active component isolated from traditional Chinese herbal medicines, and MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2H-tetrazdium) assay showed that it has no toxicity to cells. Microscale thermophoresis (MST) assay showed that paeonol can bind TOPK ex vivo. In vitro kinase assay showed paeonol can inhibit TOPK activity. Ex vivo studies further showed paeonol suppressed SUV-induced phosphorylation level of p38, JNKs, MSK1 and histone H2AX by inhibiting TOPK activity in a time and dose dependent manner. Paeonol inhibited the secretion of IL-6 and TNF-α in HaCat and JB6 cells ex vivo. In vivo studies demonstrated that paeonol inhibited SUV-induced increase of TOPK, the phosphorylation of p38, JNKs and H2AX, and the secretion of IL-6 and TNF-α in Babl/c mouse. In summary, our data indicated a protective role of paeonol against SUV-induced inflammation by targeting TOPK, and paeonol could be a promising agent for the treatment of SUV-induced skin inflammation.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.